(Q33449722)

English

Combination trial of subcutaneous interferon alfa-2b and oral cyclophosphamide in favorable histology, non-Hodgkin's lymphoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Combination trial of subcutaneous interferon alfa-2b and oral cyclophosphamide in favorable histology, non-Hodgkin's lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Clara D. Bloomfield

6

object named as

Bloomfield CD

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Ozer H

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Anderson JR

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Peterson BA

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Budman DR

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Henderson ES

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Gottlieb A

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 January 1987

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

5 Suppl

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

S27-33

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Preliminary Observations on the Effect of Human Leukocyte Interferon in Non-Hodgkin's Lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3298131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/3298131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytologic, immunologic, and clinical diversity in non-Hodgkin's lymphoma: therapeutic implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/3298131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

1 reference

https://pubmed.ncbi.nlm.nih.gov/3298131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3298131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00207260

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33449722&oldid=1536079671"